* Highlights positive top-line results from pivotal phase 3
fulfil study of closed triple announced by Glaxosmithkline,
Innoviva

The post BRIEF-Theravance Biopharma highlights positive results from phase 3 fulfil study of closed triple announced by Glaxosmithkline, Innoviva appeared first on NASDAQ.